BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells

Biochemical Pharmacology

Volumn 60, Issue 6, 2000, Pages 831-837

  Yang, Chih Hsin ^a   Schneider, Erasmus ^b,c   Kuo, Min Liang ^d   Volk, Erin L ^c   Rocchi, Emmanuelle ^b   Chen, Yao Chang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b WADSWORTH CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BCRP; Mitoxantrone; Multidrug resistance; Topotecan

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 9 AMINOCAMPTOTHECIN; BREAST CANCER RESISTANCE PROTEIN; CAMPTOTHECIN; DNA TOPOISOMERASE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; IRINOTECAN; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; TOPOTECAN; TUMOR CELLS, CULTURED;

EID: 0034666736     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00396-8     Document Type: Article

References (21)

1. Tanizawa A., Beitrand R., Kohlhagen G., Tabuchi A., Jenkins J., Pommier Y. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. J Biol Chem. 268:1993;25463-25468.
2. Woessner R.D., Eng W.K., Hofmann G.A., Rieman D.J., McCabe F.L., Hertzberg R.P., Mattern M.R., Tan K.B., Johnson R.K. Camptothecin hyper-resistant P388 cells Drug-dependent reduction in topoisomerase I content . Oncol Res. 4:1992;481-488.
3. Hendricks C.B., Rowinsky E.K., Grochow L.B., Donehower R.C., Kaufmann S.H. Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Cancer Res. 52:1992;2268-2278.
4. Pommier Y., Leteurtre F., Fesen M.R., Fujimori A., Bertrand R., Solary E., Kohlhagen G., Kohn K.W. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12:1994;530-542.
5. Nakagawa M., Schneider E., Dixon K.H., Horton J., Kelley K., Morrow C., Cowan K.H. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res. 52:1992;6175-6181.
6. Yang C.J., Horton J.K., Cowan K.H., Schneider E. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations. Cancer Res. 55:1995;4004-4009.
7. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82:1990;1107-1112.
8. Schneider E., Horton J.K., Yang C.H., Nakagawa M., Cowan K.H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:1994;152-158.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
10. Ohashi N., Fujiwara Y., Yamaoka N., Katoh O., Satow Y., Yamakido M. No alteration in DNA topoisomerase I gene related to CPT-11 resistance in human lung cancer. Jpn J Cancer Res. 87:1996;1280-1287.
11. Sorensen M., Sehested M., Jensen P.B. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan. Br J Cancer. 72:1995;399-404.
12. Ma J., Maliepaard M., Nooter K., Loos W.J., Kolker H.J., Verweij J., Stoter G., Schellens J.H. Reduced cellular accumulation of topotecan A novel mechanism of resistance in a human ovarian cancer cell line . Br J Cancer. 77:1998;1645-1652.
13. Chen A.Y., Yu C., Potmesil M., Wall M.E., Wani M.C., Liu L.F. Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. Cancer Res. 51:1991;6039-6044.
14. Kellner U., Hutchinson L., Seidel A., Lage H., Danks M.K., Dietel M., Kaufmann S.H. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int J Cancer. 71:1997;817-824.
15. Lee J.S., Scala S., Matsumoto Y., Dickstein B., Robey R., Zhan Z., Altenberg G., Bates S.E. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem. 65:1997;513-526.
16. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA. 95:1998;15665-15670.
17. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., Bates S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells Demonstration of homology to ABC transport genes . Cancer Res. 59:1999;8-13.
18. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:1998;5337-5339.
19. Ross D.D., Yang W., Abruzzo L.V., Dalton W.S., Schneider E., Lage H., Dietel M., Greenberger L., Cole S.P., Doyle L.A. Atypical multidrug resistance Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines . J Natl Cancer Inst. 91:1999;429-433.
20. Allen J.D., Brinkhuis R.F., Wijnholds J., Schinkel A.H. The mouse Bcrp1/Mxr/Abcp gene Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin . Cancer Res. 59:1999;4237-4241.
21. Maliepaard M., van Gastelen M.A., de Jong L.A., Pluim D., van Waardenburg R.C.A.M., Ruevekamp-Helmers M.C., Floot B.G.J., Schellens J.H.M. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 59:1999;4559-4563.